Survey says: Proactive quality risk management for life science companies is a must

Posted on Posted in Electronic QMS, General, london_2018

Klavs Esbjerg, CEO and founder of Epista Life Science, is on a mission to help his clients continuously improve regulatory compliance and in turn, transform their compliance obstacles into real business opportunities. The practical aspects of this vision are as important to regulatory bodies as they are to the companies Epista serves. To get clear on […]

Why digitised design control is essential for the sustainability of your DHF

Posted on Posted in General, london_2018

Thanks to Laurence Sampson for writing this article, as a preview to the upcoming conference on Practical Solutions in CSV and SDLC for GXP & MedDev (London, 3/10/2018) In today’s competitive landscape, every stage of the regulatory process – from first submission through ongoing, annual or semi-annual iterations – is a make-it- or break-it-scenario. From delays to audit failures and […]

The difference between data integrity & data quality in medical technology companies – and why you must care

The difference between data integrity & data quality in medical technology companies – and why you must care

Posted on Posted in General, london_2018

Thanks to Keith Williams for writing this article, as a preview to the upcoming conference on Practical Solutions in CSV and SDLC for GXP & MedDev (London, 3/10/2018) Data is the lifeblood of any Life Sciences company – and trust is the heart. For those of us that manage data, we cannot and will not allow drugs or medtech […]